Moderna and Merck's Cancer Vaccine Cuts Melanoma Return

A groundbreaking cancer vaccine from Moderna and Merck reduced the chances of melanoma returning after surgery in a major trial with over 1,100 patients.

Even the company's own executives didn't believe it would work.